SMNR (Semnur Pharmaceuticals) GF Score: 8/100 (As of Jul. 11, 2026) — 50% Below Median


SMNR Semnur Pharmaceuticals Inc SMNR
8 GF Score
Price $0.68
View Full Analysis

What is Semnur Pharmaceuticals GF Score?

Semnur Pharmaceuticals SMNR -9.63% 8 GF Score is 8 as of Jul. 11, 2026, which is 50% below its 10-year median of 16.00. GuruFocus rates SMNR with a GF Score™ of 8/100.

Semnur Pharmaceuticals has the GF Score of 8, which implies that the company might have Worst future performance potential, or not enough data.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 4/10
2. Profitability Rank : 1/10
3. Growth Rank : 0/10
4. GF Value Rank : 0/10
5. Momentum Rank : 0/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Semnur Pharmaceuticals might have Worst future performance potential, or not enough data.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Semnur Pharmaceuticals  (OTCPK:SMNR) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Semnur Pharmaceuticals GF Score Related Terms

SMNR vs CNTB, ENLV, MENS: GF Score Comparison

For the Biotechnology subindustry, Semnur Pharmaceuticals's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Semnur Pharmaceuticals GF Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Semnur Pharmaceuticals's GF Score distribution charts can be found below:

* The bar in red indicates where Semnur Pharmaceuticals's GF Score falls into.


SMNR
8GF Score
Semnur Pharmaceuticals Inc SMNR
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 8 mean?
Semnur Pharmaceuticals (SMNR) has a GF Score of 8 as of Jul. 11, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Semnur Pharmaceuticals and its competitors. This is 50% below median its historical median of 16.00. Over the past decade, Semnur Pharmaceuticals' GF Score has ranged from 8.00 to 20.00.
Is Semnur Pharmaceuticals' GF Score too high?
Semnur Pharmaceuticals' current GF Score of 8 is 50% below median its 10-year median of 16.00. Over the past 10 years, this metric has ranged from a low of 8.00 to a high of 20.00. Overall, Semnur Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' GF Score compare to CNTB and ENLV?
Semnur Pharmaceuticals' GF Score of 8 can be compared against companies in the Biotechnology industry. Historically, Semnur Pharmaceuticals' own GF Score has ranged from 8.00 to 20.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Biotechnology company?
A good GF Score depends on the Biotechnology industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Semnur Pharmaceuticals and its competitors. Semnur Pharmaceuticals's current GF Score is 8, which is 50% below median its own 10-year median of 16.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current GF Score of 8. The current GF Score is 8, which is 50% below median its 10-year median of 16.00. Semnur Pharmaceuticals' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current GF Score is 8 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
8GF Score

Get the complete analysis for SMNR

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.68
Price